Home/Adcendo/Dominik Mumberg, PhD
DM

Dominik Mumberg, PhD

Chief Scientific Officer

Adcendo

Therapeutic Areas

Adcendo Pipeline

DrugIndicationPhase
ADCE-D01Soft Tissue SarcomaPhase 1/2